Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × Afatinib × Clear all

NCT06085755 2025-12-15

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms